IP Library Granted Patent US 7,309,474
Granted Patent B2
US 7,309,474 · App. 10/825,984 · Granted Dec 18, 2007

Composition and process

Assignee: Cytec Technology Corp.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,309,474
App. No.
10/825,984
Granted
Dec 18, 2007
Kind
B2
Abstract

A solvent extraction composition is comprised of one or more orthohydroxyarylaldoximes and one or more othohydroxyarylketoximes, and one or more equilibrium modifiers in an amount providing a degree of modification of the orthohydroxyarylaldoximes from about 0.2 to 0.61

Claims (22)

1. A solvent extraction composition comprising one or more orthohydroxyarylaldoximes and one or more orthohydroxyarylketoximes, and one or more equilibrium modifiers selected from the group consisting of 2,2,4-trimethyl-1,3-pentanediol mono-isobutyrate, 2,2,4-trimethyl-1,3-pentanediol mono-benzoate, 2,2,4-trimethyl-1,3-pentanediol di-isobutyrate, 2,2,4-trimethyl-1,3-pentanediol di-benzoate, isobutyl heptyl ketone, nonanone, 2,6,8-trimethyl-4-nonanone, diundecyl ketone, 5,8-diethyldodecane-6,7-dione, and tridecanol, in an amount providing a degree of modification of the orthohydroxyarylaldoximes present from about 0.2 to 0.61.

2. A solvent extraction composition according to claim 1 wherein the degree of modification is from about 0.4 to 0.6.

3. A solvent extraction composition according to claim 1 or 2 wherein the orthohydroxyarylketoximes are compounds of formula:

wherein

R 1 is an optionally substituted hydrocarbyl group

R 2 is an optionally substituted ortho-hydroxyaryl group, and salts thereof, and the orthohydroxyarylaldoxime are compounds of the formula:

wherein

R 3 is an optionally substituted ortho-hydroxyaryl group, and salts thereof.

4. A solvent extraction composition according to claim 3 wherein the orthohydroxyarylketoxime is a 5-(C 8 to C 14 alkyl)-2-hydroxyacetophenone oxime, and the orthohydroxyarylaldoxime is a 5-(C 8 to C t4 alkyl)-2-hydroxybenzaldoxime.

5. A solvent extraction composition according to claim 1 wherein the orthohydroxyarylketoxime is 2-hydroxy-5-nonylbenzophenone oxime, and the orthohydroxyarylaldoxime is 2-hydroxy-5-nonylsalicylaldoxime and the equilibrium modifier is 2,2,4-trimethyl-1,3-pentanediol di-isobutyrate.

6. A process for the extraction of a metal from solution in which an acidic solution containing a dissolved metal is contacted with a solvent extraction composition, whereby at least a fraction of the metal is extracted into the organic solution, characterised in that the solvent extraction composition comprises a water immiscible organic solvent, one or more orthohydroxyarylaldoximes and one or more orthohydroxyarylketoximes, and one or more equilibrium modifiers selected from the group consisting of 2,2,4-trimethyl-1,3-pentanediol mono-isobutyrate, 2,2,4-trimethyl-1,3-pentanediol mono-benzoate, 2,2,4-trimethyl-1,3-pentanediol di-isobutyrate, 2,2,4-trimethyl-1,3-pentanediol di-benzoate, isobutyl heptyl ketone, nonanone, 2,6,8-trimethyl-4-nonanone, diundecyl ketone, 5,8-diethyldodecane-6,7-dione, and tridecanol in an amount providing a degree of modification of the orthohydroxyarylaldoximes present from about 0.2 to 0.61.

7. A process according to claim 6 wherein the metal is copper, cobalt, nickel, manganese or zinc.

8. A process according to claim 7 wherein the degree of modification is from about 0.4 to 0.6.

9. A process according to any one of claims 6 , 7 or 8 wherein the orthohydroxyarylketoximes are compounds of formula:

wherein

R 1 is an optionally substituted hydrocarbyl group

R 2 is an optionally substituted ortho-hydroxyaryl group, and salts thereof,

and the orthohydroxyarylaldoxime are compounds of the formula:

wherein

R 3 is an optionally substituted ortho-hydroxyaryl group, and salts thereof.

10. A process according to claim 9 wherein the orthohydroxyarylketoxime is a 5-(C 8 to C 14 alkyl)-2-hydroxyacetophenone oxime, and the orthohydroxyarylaldoxime is a 5-(C 8 to C 14 alkyl)-2-hydroxybenzaldoxime.

11. A process according to claim 10 wherein the orthohydroxyarylketoxime is 2-hydroxy-5-nonylbenzophenone oxime, and the orthohydroxyarylaldoxime is 2-hydroxy-5-nonylsalicylaldoxime and the equilibrium modifier is 2,2,4-trimethyl-1,3-pentanediol di-isobutyrate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2004
From: SODERSTROM, MATTHEW D.
To: CYTEC TECHNOLOGY CORP.
Reel/Frame 015230/0613 →
Continuity (1)
Related Publication 20040208807A1 · Oct 21, 2004